• Health & Medicine

Advanced ovarian cancer drug gets initial ‘no’ for NHS in England

A targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England. A targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.

9 August 2019

• Health & Medicine

Makeup of bacteria in pancreatic tumours linked to survival

US researchers have found a link between the makeup of bacteria in the tumours of people with pancreatic cancer and how long they live. US researchers have found a link between the makeup of bacteria in the tumours of people with pancreatic cancer and how long they live.

9 August 2019

• Health & Medicine

Lung cancer immunotherapy combo added to Cancer Drugs Fund

Combining an immunotherapy with chemotherapy has been recommended as a treatment for some patients with lung cancer on the NHS in England. Combining an immunotherapy with chemotherapy has been recommended as a treatment for some patients with lung cancer on the NHS in England.

8 August 2019

• Health & Medicine

Cancer Research UK and Hummingbird Bioscience join forces to advance novel antibody drug into clinical trials

Cancer Research UK and Hummingbird Bioscience announce a partnership to develop anti-HER3 antibody drug for the treatment of people with HER3 driven cancer Cancer Research UK and Hummingbird Bioscience announce a partnership to develop anti-HER3 antibody drug for the treatment of people with HER3 driven cancer

8 August 2019

• Science & Technology
• For Supporters

Scientists in Wales awarded £514k to develop new bowel cancer test

Scientists in Wales have received £514,000 from Cancer Research UK to develop a new test using Salmonella which aims to detect bowel cancer at an early stage. Scientists in Wales have received £514,000 from Cancer Research UK to develop a new test using Salmonella which aims to detect bowel cancer at an early stage.

7 August 2019

• Health & Medicine

Highly sensitive blood test could improve breast cancer treatment

A new blood test is one of the first to successfully monitor early-stage breast cancer, and could be up to 100 times more sensitive than existing tests. A new blood test is one of the first to successfully monitor early-stage breast cancer, and could be up to 100 times more sensitive than existing tests.

7 August 2019

• Health & Medicine
• Science & Technology

News digest – aspirin, breast cancer blood test, Boris Johnson’s NHS plans and bowel cancer rates in young people 

NICE makes draft recommendation on daily aspirin for people with Lynch syndrome to reduce bowel cancer risk and blood test could detect breast cancer relapse. NICE makes draft recommendation on daily aspirin for people with Lynch syndrome to reduce bowel cancer risk and blood test could detect breast cancer relapse.

3 August 2019

• Health & Medicine

Daily aspirin reduces bowel cancer risk in people with Lynch syndrome, says NICE

Taking a daily aspirin for more than two years could reduce the risk of bowel cancer in people with Lynch syndrome, according to new draft guidance from NICE. Taking a daily aspirin for more than two years could reduce the risk of bowel cancer in people with Lynch syndrome, according to new draft guidance from NICE.

2 August 2019

• For Researchers

How to broaden the reach of your research

Henry Scowcroft explores how blogs, social media and traditional media can raise the profile of research groups and build public trust in science. Henry Scowcroft explores how blogs, social media and traditional media can raise the profile of research groups and build public trust in science.

1 August 2019

• Policy & Insight

Opinion: ‘Building an NHS workforce for the future must be Boris Johnson’s top health priority’

With a new Prime Minister in office, the Government's commitments to supporting the NHS and building on the strength of science in the UK must become reality. With a new Prime Minister in office, the Government's commitments to supporting the NHS and building on the strength of science in the UK must become reality.

31 July 2019

• Science & Technology

Tumour liquefying microbubbles: UK’s first convergence science centre officially launches

Using ultrasound technology to liquefy cancer cells is just one of the projects at the new £13 million Cancer Research UK Convergence Science Centre. Using ultrasound technology to liquefy cancer cells is just one of the projects at the new £13 million Cancer Research UK Convergence Science Centre.

29 July 2019

• Health & Medicine
• Science & Technology

News digest – smokefree 2030, NICE decision, proton beam therapy and CAR T cell boost in mice

In the news this week: The government sets a smokefree target of 2030 for England and can eating fish reduce your risk of bowel cancer? In the news this week: The government sets a smokefree target of 2030 for England and can eating fish reduce your risk of bowel cancer?

27 July 2019